Please ensure Javascript is enabled for purposes of website accessibility

Why Neuronetics Blasted 39% Higher Today

By Eric Volkman - May 4, 2021 at 5:41PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company is experiencing a strong rise in demand.

What happened

Neuronetics (STIM -0.94%), a company that focuses on what it describes as "products that improve the quality of life for patients who suffer from psychiatric disorders," shot 39% higher on Tuesday. Investors were likely impressed by the company's potential as indicated in its first-quarter results.

So what

Neuronetics earned $12.3 million in revenue for the quarter, 7% higher on a year-over-year basis. As is its habit of late, the healthcare company posted a net loss. However, this narrowed to just under $7.9 million ($0.31 per share) from the Q1 2020 shortfall of $12.6 million.

Medical pro holding dollar sign paperweight.

Image source: Getty Images.

Both headline figures beat the average analyst estimates of $11.6 million for revenue and a bottom-line deficit of $0.33 per share.

Neuronetics specializes in transcranial magnetic stimulation (TMS) in which magnetic fields are used to stimulate nerve cells located in a part of the brain associated with mood in order to help alleviate clinical depression.

With depression apparently on the rise due to the psychological effects of the coronavirus pandemic, Neuronetics is experiencing significantly higher demand for its TMS therapy. The company reported that it has witnessed a 30% rise in patients requesting appointments.

Now what

Neuronetics has increased its guidance for full-year 2021: Revenue should be $59 million to $63 million, up from the previous $58 million to $62 million estimate. A profitability estimate wasn't provided. 

Regardless, investors like the sound of a 30% demand rise; it's no wonder that the stock rose at a rate not far from that figure.


Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Neuronetics, Inc. Stock Quote
Neuronetics, Inc.
$3.18 (-0.94%) $0.03

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/04/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.